Literature DB >> 32796061

Interaction Interface of Mason-Pfizer Monkey Virus Matrix and Envelope Proteins.

Jan Prchal1,2, Jakub Sýs2,3, Petra Junková2,3, Jan Lipov2, Tomáš Ruml4.   

Abstract

Retroviral envelope glycoprotein (Env) is essential for the specific recognition of the host cell and the initial phase of infection. As reported for human immunodeficiency virus (HIV), the recruitment of Env into a retroviral membrane envelope is mediated through its interaction with a Gag polyprotein precursor of structural proteins. This interaction, occurring between the matrix domain (MA) of Gag and the cytoplasmic tail (CT) of the transmembrane domain of Env, takes place at the host cell plasma membrane. To determine whether the MA of Mason-Pfizer monkey virus (M-PMV) also interacts directly with the CT of Env, we mimicked the in vivo conditions in an in vitro experiment by using a CT in its physiological trimeric conformation mediated by the trimerization motif of the GCN4 yeast transcription factor. The MA protein was used at the concentration shifting the equilibrium to its trimeric form. The direct interaction between MA and CT was confirmed by a pulldown assay. Through the combination of nuclear magnetic resonance (NMR) spectroscopy and protein cross-linking followed by mass spectrometry analysis, the residues involved in mutual interactions were determined. NMR has shown that the C terminus of the CT is bound to the C-terminal part of MA. In addition, protein cross-linking confirmed the close proximity of the N-terminal part of CT and the N terminus of MA, which is enabled in vivo by their location at the membrane. These results are in agreement with the previously determined orientation of MA on the membrane and support the already observed mechanisms of M-PMV virus-like particle transport and budding.IMPORTANCE By a combination of nuclear magnetic resonance (NMR) and mass spectroscopy of cross-linked peptides, we show that in contrast to human immunodeficiency virus type 1 (HIV-1), the C-terminal residues of the unstructured cytoplasmic tail of Mason-Pfizer monkey virus (M-PMV) Env interact with the matrix domain (MA). Based on biochemical data and molecular modeling, we propose that individual cytoplasmic tail (CT) monomers of a trimeric complex bind MA molecules belonging to different neighboring trimers, which may stabilize the MA orientation at the membrane by the formation of a membrane-bound net of interlinked Gag and CT trimers. This also corresponds with the concept that the membrane-bound MA of Gag recruits Env through interaction with the full-length CT, while CT truncation during maturation attenuates the interaction to facilitate uncoating. We propose a model suggesting different arrangements of MA-CT complexes between a D-type and C-type retroviruses with short and long CTs, respectively.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Env; M-PMV; Retrovirus; cytoplasmic tail; protein interactions

Mesh:

Substances:

Year:  2020        PMID: 32796061      PMCID: PMC7527036          DOI: 10.1128/JVI.01146-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome.

Authors:  Jeffrey N Sfakianos; Eric Hunter
Journal:  Traffic       Date:  2003-10       Impact factor: 6.215

2.  Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.

Authors:  Y Morikawa; W H Zhang; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Distance restraints from crosslinking mass spectrometry: mining a molecular dynamics simulation database to evaluate lysine-lysine distances.

Authors:  Eric D Merkley; Steven Rysavy; Abdullah Kahraman; Ryan P Hafen; Valerie Daggett; Joshua N Adkins
Journal:  Protein Sci       Date:  2014-04-03       Impact factor: 6.725

4.  A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein.

Authors:  B A Brody; S S Rhee; M A Sommerfelt; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 7.  Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).

Authors:  Satinder S Rawat; Mathias Viard; Stephen A Gallo; Alan Rein; Robert Blumenthal; Anu Puri
Journal:  Mol Membr Biol       Date:  2003 Jul-Sep       Impact factor: 2.857

8.  The structure of myristoylated Mason-Pfizer monkey virus matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in its membrane binding.

Authors:  Jan Prchal; Pavel Srb; Eric Hunter; Tomáš Ruml; Richard Hrabal
Journal:  J Mol Biol       Date:  2012-08-02       Impact factor: 5.469

9.  The CCPN data model for NMR spectroscopy: development of a software pipeline.

Authors:  Wim F Vranken; Wayne Boucher; Tim J Stevens; Rasmus H Fogh; Anne Pajon; Miguel Llinas; Eldon L Ulrich; John L Markley; John Ionides; Ernest D Laue
Journal:  Proteins       Date:  2005-06-01

10.  Mason-Pfizer Monkey Virus Envelope Glycoprotein Cycling and Its Vesicular Co-Transport with Immature Particles.

Authors:  Petra Grznárová Prokšová; Jan Lipov; Jaroslav Zelenka; Eric Hunter; Hana Langerová; Michaela Rumlová; Tomáš Ruml
Journal:  Viruses       Date:  2018-10-20       Impact factor: 5.048

View more
  2 in total

1.  Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.

Authors:  Paige Haas; Monita Muralidharan; Nevan J Krogan; Robyn M Kaake; Ruth Hüttenhain
Journal:  J Proteome Res       Date:  2021-01-19       Impact factor: 4.466

2.  Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.

Authors:  Merve Cakir; Kirsten Obernier; Antoine Forget; Nevan J Krogan
Journal:  mSystems       Date:  2021-09-14       Impact factor: 6.496

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.